Acquisition of Cynosure, Inc. (CYNO) Under Investigation for Investors
The takeover of Cynosure, Inc is under investigation over potential wrongdoing. The investigation was announced for investors, who currently hold shares of Cynosure, Inc. (NASDAQ:CYNO), concerning whether the takeover of Cynosure, Inc. by Hologic, Inc for $66.00 per share. is unfair.
View full press release